Selling And Administration Expenses Cambio Fecha
AbbVie USD 3.61B 273M 2023-12
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
Acorda Therapeutics USD 21.82M 689K 2023-06
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
ALKERMES USD 167.95M 37.31M 2023-09
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amgen USD 1.76B 424M 2023-12
Biogen USD 608.5M 179.7M 2023-12
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Cytokinetics USD 44.11M 4M 2023-12
Dynavax Technologies USD 39.79M 2.63M 2023-12
Enanta Pharmaceuticals USD 13.8M 1.18M 2023-09
Exelixis USD 138.14M 3.58M 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
Incyte USD 293.86M 25.97M 2023-12
Intra Cellular Therapies USD 104.72M 487K 2023-12
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
Nektar Therapeutics USD 21.15M 3.28M 2023-09
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Repligen USD 57.51M 3.31M 2023-12
Rigel Pharmaceuticals USD 24.86M 1.45M 2023-09
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Teva Pharmaceutical Industries USD 844M 66M 2023-09
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09
Xoma USD 6.37M 591K 2023-09



Neurocrine Biosciences Gastos De Venta Y Administración - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.